NEW YORK (GenomeWeb News) – Cepheid this week received CE marking for its Xpert CT/NG and Xpert CT tests, and the firm said it would begin shipping the tests in Europe immediately. The tests are for rapid detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhea and run on Cepheid's GeneXpert System.


The Board of Directors of Becton Dickinson has declared a quarterly dividend of $.45 per share. The dividend is payable on June 29 to shareholders of record on June 8.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.